On May 23, 2023 Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, reported that it will participate in the SVB Securities Biopharma Company Connect event, taking place virtually May 24th- 25th, 2023 (Press release, Myeloid Therapeutics, MAY 23, 2023, View Source [SID1234631978]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Myeloid management will participate in virtual one-on-one meetings with investors during the event.